Oxford Nanopore Technologies (ONTTF) Stock Price, News & Analysis

Company Overview

Oxford Nanopore Technologies plc is a biotechnology company that develops and supplies nanopore-based DNA and RNA sequencing technologies. Its platforms analyze genetic material by detecting changes in electrical current as nucleic acid molecules pass through engineered nanopores, enabling real-time sequencing and the characterization of long DNA and RNA fragments.

The company’s product portfolio includes the portable MinION and smaller sequencing devices, as well as higher-throughput systems such as GridION and PromethION. Oxford Nanopore also provides sequencing consumables, flow cells, library-preparation products, software and data-analysis tools, including its EPI2ME workflows. These products are used in research, clinical and public-health applications, drug development, agriculture, industrial biotechnology, and environmental analysis.

Oxford Nanopore was founded in 2005 as a spinout from the University of Oxford and introduced its MinION platform to the market in the 2010s. The company serves customers and research institutions internationally through direct operations, distributors and commercial partnerships. Its shares are listed on the London Stock Exchange, and the company’s American OTC Markets trading symbol is ONTTF.

Key Stats

• Today's Range: $2.87 to $2.87
• 50-Day Range: $1.58 to $3.05
• 52-Week Range: $1.27 to $3.18
• Volume: 1,000 shs
• Average Volume: 32,153 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:ONTTF
• Previous Symbol: OTC:ONTTF
• CIK: N/A
• Web: nanoporetech.com
• Phone: 44 84 5034 7900
• Fax: N/A
• Employees: 1,403
• Year Founded: 2005

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A